---
title: "European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279818306.md"
description: "European equities traded in the US saw a decline in American depositary receipts, with the S&P Europe Select ADR Index falling 0.5% to 1,711.73. Notable gainers included Equinor (8.5%) and Eni (3.2%), while Banco Santander (-2.8%) and Grifols (-3.1%) were among the decliners. In the UK, BP rose 4.3% and Amarin 1.3%, whereas Biodexa Pharmaceuticals fell 9.8% and NuCana 3.5%."
datetime: "2026-03-19T15:25:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279818306.md)
  - [en](https://longbridge.com/en/news/279818306.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279818306.md)
---

# European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

11:25 AM EDT, 03/19/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were down sharply late Thursday morning, as the S&P Europe Select ADR Index dropped 0.5% to 1,711.73.

From continental Europe, the gainers were led by petroleum refiner Equinor ( EQNR ) and oil and gas company Eni (E), which climbed 8.5% and 3.2% respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and software firm SAP (SAP), which advanced 2.4% and 0.7% respectively.

The decliners from continental Europe were led by lender Banco Santander (SAN) and biopharmaceutical company Grifols ( GRFS ) , which dropped 2.8% and 3.1% respectively. They were followed by telecommunications company Nokia ( NOK ) and biotech firm BioNTech (BNTX), which were down 2% and 1.5% respectively.

The gainers from the UK were led by oil and gas company BP (BP) and biopharmaceutical company Amarin ( AMRN ) , which rose 4.3% and 1.3% respectively. They were followed by biotech company Trinity Biotech ( TRIB ) and cruise line operator Carnival (CUK), which were up 0.9% and 0.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which fell 9.8% and 3.5% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were down 14% and 2.7% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [EQNR.US](https://longbridge.com/en/quote/EQNR.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [E.US](https://longbridge.com/en/quote/E.US.md)
- [SAN.US](https://longbridge.com/en/quote/SAN.US.md)
- [STOHF.US](https://longbridge.com/en/quote/STOHF.US.md)
- [EIPAF.US](https://longbridge.com/en/quote/EIPAF.US.md)
- [AMRN.US](https://longbridge.com/en/quote/AMRN.US.md)
- [BP.US](https://longbridge.com/en/quote/BP.US.md)
- [GRFS.US](https://longbridge.com/en/quote/GRFS.US.md)
- [FDD.US](https://longbridge.com/en/quote/FDD.US.md)
- [BPH.US](https://longbridge.com/en/quote/BPH.US.md)
- [SPEU.US](https://longbridge.com/en/quote/SPEU.US.md)

## Related News & Research

- [Amarin Shareholders Reject Dilution, Governance Proposals at AGM](https://longbridge.com/en/news/286548345.md)
- [Grifols Calls June 2026 Shareholders’ Meeting With Broad Capital and Governance Mandate](https://longbridge.com/en/news/286598481.md)
- [Eni Advances May 2026 Treasury Share Buyback for Long-Term Incentive Plan](https://longbridge.com/en/news/287091067.md)
- [BREAKINGVIEWS-Berlin’s 2022 Uniper bailout could turn profitable](https://longbridge.com/en/news/286898283.md)
- [Indonesia, Malaysia have approved asset transfers to new Eni-Petronas JV, Petronas exec says](https://longbridge.com/en/news/287212668.md)